Decoding the Myeloid-Derived Suppressor Cells in Lymphoid Malignancies

J Clin Med. 2021 Aug 4;10(16):3462. doi: 10.3390/jcm10163462.

Abstract

Myeloid-derived suppressor cells (MDSCs) are immature myeloid precursors which emerged as a potent regulator of the immune system, exerting suppressive properties in diverse disease settings. In regards to cancer, MDSCs have an established role in solid tumors; however, their contribution to immune regulation during hematologic malignancies and particularly in lymphomas remains ill-defined. Herein focused on lymphoma, we discuss the literature on MDSC cells in all histologic types, and we also refer to lessons learned by animal models of lymphoma. Furthermore, we elaborate on future directions and unmet needs and challenges in the MDSC field related to lymphoma malignancies which may shed light on the complex nature of the immune system in malignancies.

Keywords: Myeloid-derived suppressor cells; immune regulation; lymphomas.

Publication types

  • Review